Swiss Nuclear Forum Launches Dedicated Nuclear Medicine Section
New body will be led by Dr Konrade von Bremen
New body will be led by Dr Konrade von Bremen
Focus of new facility will be lutetium-177 and other therapeutic isotopes
Texas facility part of company’s broader effort to build US production capabilities
Nuclear company moved from groundbreaking to authorisation in just over 10 months
Global medical imaging and cancer treatment supply chain heavily dependent on concentrated group of ageing reactors
Register free and get full access to NucNet for 14 days. No card required.
After the trial, keep a free account for a newsletter and a complimentary Plus article every two weeks. Or see our subscription plans for individuals and organisations.
See subscription options